M Kobayashi, H Ikegami, T Fujisawa, K Nojima, Y … - Diabetes, 2007 - Am Diabetes Assoc Bile acid–binding resins, such as cholestyramine and colestimide, have been clinically used
as cholesterol-lowering agents. These agents bind bile acids in the intestine and reduce enterohepatic
circulation of bile acids, leading to accelerated conversion of cholesterol to bile acids. A ... Cited by 25 - Related articles - BL Direct - All 5 versions
T YAMAKAWA, T TAKANO, H UTSUNOMIYA, K … - Endocrine journal, 2007 - cat.inist.fr Colestimide is a new anion-exchange resin used to lower serum cholesterol in Japan. Because
of its excellent compliance, colestimide can replace cholestyramine. To clarify the effect of colestimide
on glycemic controls, colestimide(3 g/day) or pravastatin(10 mg) was given orally to ... Cited by 22 - Related articles - BL Direct - All 4 versions
- ►nms.ac.jp [PDF] T Suzuki, K Oba, S Futami, K Suzuki, M Ouchi, Y … - Journal of Nippon …, 2006 - J-STAGE Page 1. ―Original― Blood Glucose-lowering Activity of Colestimide in Patients with Type 2
Diabetes and Hypercholesterolemia: A Case-control Study Comparing Colestimide with Acarbose
Tatsuya Suzuki 1,2 , Kenzo Oba 1,2 , Shoko Futami 1,2 , Kazunari Suzuki 1,2 , ... Cited by 12 - Related articles - BL Direct - All 5 versions
- ►adisonline.com B Staels, F Kuipers - Drugs, 2007 - ingentaconnect.com Bile acids promote bile formation and facilitate dietary lipid absorption. Abstract Animal and human
studies showing disturbed bile acid metabolism in diabetes mellitus suggest a link between bile
acids and glucose control. Bile acids are activating ligands of the farnesoid X receptor ... Cited by 30 - Related articles - BL Direct - All 8 versions
[CITATION] Bile acid binding resin ameliorates glycemic control in patients with type 2 diabetes
T Onishi, N Sano, H Takikawa - Journal of gastroenterology and …, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 8 - Related articles - BL Direct - All 5 versions
- ►endocrinology-journals.org T Maruyama, K Tanaka, J Suzuki, H Miyoshi, … - Journal of …, 2006 - Soc Endocrinology G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) is a novel G protein-coupled receptor
for bile acid. Tissue distribution and cell-type specificity of Gpbar1 mRNA suggest a potential
role for the receptor in the endocrine system; however, the precise physiological role of ... Cited by 17 - Related articles - BL Direct - All 7 versions
- ►nms.ac.jp [PDF] T Suzuki, K Oba, Y Igari, N Matsumura, K Watanabe … - Journal of Nippon …, 2007 - J-STAGE Page 1. 338 J Nippon Med Sch 2007; 74 (5) ―Original― Colestimide Lowers Plasma
Glucose Levels and Increases Plasma Glucagon-like Peptide-1 (7―36) Levels in Patients
with Type 2 Diabetes Mellitus Complicated by Hypercholesterolemia ... Cited by 13 - Related articles - BL Direct - All 3 versions
- ►adisonline.com [PDF] K Koike, K Murakami, N Nozaki, K Sugiura, M … - Drugs in R&# 38; …, 2005 - ingentaconnect.com 1174-5886/05/0005-0273/$34.95/0 2005 Adis Data Information BV. All rights reserved. ...
Koji Koike,1 Kouichi Murakami,1 Noriko Nozaki,1 Kouichi Sugiura2 and Masaki Inoue1 ... 1
Department of Obstetrics and Gynecology, Kanazawa University Graduate School of ... Cited by 3 - Related articles - BL Direct - All 4 versions
B Cariou, K van Harmelen, D Duran-Sandoval, TH … - Journal of Biological …, 2006 - ASBMB The farnesoid X receptor (FXR) is a bile acid (BA)-activated nuclear receptor that plays a major
role in the regulation of BA and lipid metabolism. Recently, several studies have suggested a
potential role of FXR in the control of hepatic carbohydrate metabolism, but its ... Cited by 69 - Related articles - BL Direct - All 7 versions
